Cell-Easy
Toulouse, FR
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
76.8
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (1)
✓ EMA GMP (2)
○ MHRA GMP
Quick Facts: Cell-Easy
- Signal Score
- 76.8/100 (as of 2026-10-29)
- Quality Compliance
- 100.0/100
- Headquarters
- Toulouse, FR
- Modalities
- Cell Therapy
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Cell-Easy
Pure-play CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
FDA InspectionsNo US records on file
EMA GMP Certificates2 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
53.0
1 manufacturing site: Toulouse, FR
Modalities: Cell Therapy
Capacity assessment: 53.0/100
Sites: Toulouse, FR
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals1 articles (not scored)
1 manufacturing site: Toulouse, FR
Modalities: Cell Therapy
Capacity assessment: 53.0/100
Cell-Easy EMA GMP Compliance 2 certificates
2024-02
2022-02
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| 2024_HPF_FR_090 | Cell-Easy | France | 2024-02-01 | COMPLIANT |
| 2022_HPF_FR_065 | Cell-Easy | France | 2022-02-18 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 21, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Company Signals 1 articles
Company announcements, not verified evidence. They do not change any score.
Cell-Easy Launches an iPSC-Derived Beta Cell Program to Tackle Scale-Up Challenges - BioInformant
Cell-Easy Launches an iPSC-Derived Beta Cell Program to Tackle Scale-Up Challenges BioInformant
Frequently Asked Questions About Cell-Easy
Does Cell-Easy hold EMA or MHRA GMP certificates?
CDMO Signal tracks 2 EMA GMP certificates for Cell-Easy.
What is Cell-Easy's CDMO Signal Score?
Cell-Easy has a Signal Score of 77/100, based on quality, operations, financial stability, and capacity data.
Evaluating Cell-Easy for a manufacturing program?
Use the free AI matchmaker to compare Cell-Easy against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
CELLforCURE (SEQENS)
Les Ulis, FR
Signal Score: 80.3
CAR-T, Cell Therapy
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 87.0
CAR-T, Cell Therapy
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 84.0
CAR-T, Cell Therapy
Takeda
Boston, MA · Zurich, CH
Signal Score: 83.4
AAV, Cell Therapy
Compare Cell-Easy with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.